A carregar...
Neoantigen Vaccines Pass the Immunogenicity Test
Neoantigens arising from tumor-specific genomic alterations constitute authentic “non-self” antigens and represent a new class of targets for cancer immunotherapy. Recent reports on various vaccine platforms targeting neoantigens suggest a basis for precision therapies customized to each patient’s t...
Na minha lista:
| Publicado no: | Trends Mol Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624828/ https://ncbi.nlm.nih.gov/pubmed/28867556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmed.2017.08.007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|